Angus Russell, chief executive of the speciality pharmaceutical firm Shire, has taken advantage of a strong performance from the group recently to sell a big chunk of shares.
He offloaded 17,219 at 1,029p each, or a total of about £177,000.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Shares in Shire have rallied strongly in the past couple of months.
The company received a boost on Tuesday when it said data from the final two Phase III trials for its Gaucher disease treatment velaglucerase alfa met expectations.
Top Director Buys
Value: £75,200
Value: $68,000
Value: £44,183
Value: £15,610
Top Director Sells
Value: £952,400
Value: £524,097
Value: £191,350
Value: £177,184
Value: £13,022
-
Reeves warned against property tax shake-up – 3 ways it could backfire on first-time buyersRachel Reeves reportedly has her eye on high-end property taxes in the upcoming Budget, but there are concerns a shake-up could unintentionally hamper those trying to get on the housing ladder
-
Average Brits want to retire five years before they can – who has the widest retirement gap?Brits are expecting to work for longer than ever but there are big disparities in the number of extra working years predicted. A small tweak could help close the gap
